Dalfampridine ER Improves Walking in Veterans with MS

by U.S. Medicine

March 10, 2014
PORTLAND, OR — In a recent study, Portland VAMC researchers found that, in short-term trials, dalfampridine extended release (ER) improves walking in veterans with multiple sclerosis (MS). In the study, which was published recently in Multiple Sclerosis Journal, the authors noted that the tolerability and effects of dalfampridine-ER in clinical practice had not previously been reported.1 For the study, all patients at the Portland VAMC prescribed dalfampridine-ER over one year completed the Timed 25-Foot Walk (T25FW), Multiple Sclerosis Walking Scale-12 (MSWS-12), Two-Minute Timed Walk (2MTW) and Community Integration Questionnaire (CIQ) at baseline and follow-up clinic visits. Ongoing use and measures were then analyzed. The 39 participants averaged 56.5 years old and were 82% male. Their mean disease duration was 20 years, with 38% having relapsing-remitting MS and 62% progressive MS. According to the results, all measures improved significantly from baseline at initial follow-up — T25FW: -2.7 s, p = 0.004; 2MTW: 41 feet (ft), p = 0.002; MSWS12: -11, p < 0.001; CIQ: 1.2, p = 0.003. After one year, walking endurance and self-perceived walking were significantly improved — 2MTW: 33 ft, p = 0.03; MSWS-12: 5.9, p = 0.007. “Dalfampridine-ER was associated with short-term improvements in walking speed and community participation, and sustained improvements in walking endurance and self-perceived impact of MS on walking for one year,” the authors concluded. “Our study supports the utility of this medication in late MS.” 1Cameron MH, Fitzpatrick M, Overs S, Murchison C, Manning J, Whitham R. Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study. Mult Scler. 2013 Nov 7. [Epub ahead of print] PubMed PMID: 24099749.

Comments are closed here.

Related Articles

VA-led Study Finds U.S. MS Prevalence Is Double Previous Estimates

WASHINGTON—Researchers and policy makers estimated that 300,000 to 400,000 people in the U.S. had multiple sclerosis in 2010, but new data indicates that number grossly undercounted the number of people affected by the neurological disease.... View Article

New Biomarker for MS Discovered; Could Replace MRI for Detection

BALTIMORE—A University of Maryland research team has discovered a biomarker that can determine whether a patients has multiple sclerosis or is relapsing, thanks to VA funding. Now two VA organizations focused on technology transfer are... View Article

U.S. Medicine Recommends

More From 2014 issues

2014 Issues

VA Slammed for Slow Action Against Officials Behind Wait-Time Scandal

Legislators: Only Four Senior Executives Removed by Mid-November

2014 Issues

VA Launches Largest Overhaul Ever as McDonald Pushes Reforms

WASHINGTON - New VA Secretary Robert McDonald continues to methodically tackle the issues that have caused a breakdown in efficient veteran care over the last few years, now pushing the agency to undertake the largest reorganization since its founding.

2014 Issues

VA’s IT Security Controls Cited for 15th Year in a Row

Controversial Scheduling System Will Be Replaced in 2015

2014 Issues

Study Offers New Statistics on How Many OEF/OIF Veterans Have PTSD

Condition Not Just Related to Deployment By Brenda L. Mooney WASHINGTON – While many studies have reported the prevalence of post-traumatic stress disorder (PTSD) in Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) veterans, most... View Article

2014 Issues

Danger of Pneumonia Increases with Veterans’ Worsened Health Status

Higher Pneumonia Vaccine Rates Urged By Brenda L. Mooney PROVIDENCE, RI – With influenza season each year comes an even greater challenge for VA hospitals — a spate of pneumonia cases in older veterans. Recent... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up